Clinical trial

Irbesartan in Type 2 Diabetes

NCT00317915

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE3

Study timeline

Registry last updated2006-04-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Microalbuminuriaunresolved

Hypertensionunresolved

Interventions

Irbesartan treatmentDRUG

Sponsors & collaborators

Steno Diabetes Center Copenhagenlead sponsor

Bristol-Myers Squibbcollaborator

Sanofi-Synthelabocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00317915 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.